Copyright Reports & Markets. All rights reserved.

Global Mecobalamin Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Mecobalamin Injection Market Overview

  • 1.1 Product Overview and Scope of Mecobalamin Injection
  • 1.2 Mecobalamin Injection Segment by Type
    • 1.2.1 Global Mecobalamin Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Intramuscular Injection
    • 1.2.3 Intravenous Injection
  • 1.3 Mecobalamin Injection Segment by Application
    • 1.3.1 Mecobalamin Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
    • 1.3.4 Other
  • 1.4 Global Mecobalamin Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Mecobalamin Injection Revenue 2016-2027
    • 1.4.2 Global Mecobalamin Injection Sales 2016-2027
    • 1.4.3 Mecobalamin Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Mecobalamin Injection Market Competition by Manufacturers

  • 2.1 Global Mecobalamin Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Mecobalamin Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Mecobalamin Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Mecobalamin Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Mecobalamin Injection Market Competitive Situation and Trends
    • 2.5.1 Mecobalamin Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Mecobalamin Injection Players Market Share by Revenue
    • 2.5.3 Global Mecobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mecobalamin Injection Retrospective Market Scenario by Region

  • 3.1 Global Mecobalamin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Mecobalamin Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Mecobalamin Injection Market Facts & Figures by Country
    • 3.3.1 North America Mecobalamin Injection Sales by Country
    • 3.3.2 North America Mecobalamin Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Mecobalamin Injection Market Facts & Figures by Country
    • 3.4.1 Europe Mecobalamin Injection Sales by Country
    • 3.4.2 Europe Mecobalamin Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Mecobalamin Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Mecobalamin Injection Sales by Region
    • 3.5.2 Asia Pacific Mecobalamin Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Mecobalamin Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Mecobalamin Injection Sales by Country
    • 3.6.2 Latin America Mecobalamin Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Mecobalamin Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Mecobalamin Injection Sales by Country
    • 3.7.2 Middle East and Africa Mecobalamin Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Mecobalamin Injection Historic Market Analysis by Type

  • 4.1 Global Mecobalamin Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Mecobalamin Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Mecobalamin Injection Price by Type (2016-2021)

5 Global Mecobalamin Injection Historic Market Analysis by Application

  • 5.1 Global Mecobalamin Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Mecobalamin Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Mecobalamin Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Empower Pharmacy
    • 6.1.1 Empower Pharmacy Corporation Information
    • 6.1.2 Empower Pharmacy Description and Business Overview
    • 6.1.3 Empower Pharmacy Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Empower Pharmacy Product Portfolio
    • 6.1.5 Empower Pharmacy Recent Developments/Updates
  • 6.2 SGPharma
    • 6.2.1 SGPharma Corporation Information
    • 6.2.2 SGPharma Description and Business Overview
    • 6.2.3 SGPharma Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 SGPharma Product Portfolio
    • 6.2.5 SGPharma Recent Developments/Updates
  • 6.3 Eisai China
    • 6.3.1 Eisai China Corporation Information
    • 6.3.2 Eisai China Description and Business Overview
    • 6.3.3 Eisai China Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Eisai China Product Portfolio
    • 6.3.5 Eisai China Recent Developments/Updates
  • 6.4 Harbin Medisan Pharmaceutical
    • 6.4.1 Harbin Medisan Pharmaceutical Corporation Information
    • 6.4.2 Harbin Medisan Pharmaceutical Description and Business Overview
    • 6.4.3 Harbin Medisan Pharmaceutical Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Harbin Medisan Pharmaceutical Product Portfolio
    • 6.4.5 Harbin Medisan Pharmaceutical Recent Developments/Updates
  • 6.5 Yangtze River Pharmaceutical
    • 6.5.1 Yangtze River Pharmaceutical Corporation Information
    • 6.5.2 Yangtze River Pharmaceutical Description and Business Overview
    • 6.5.3 Yangtze River Pharmaceutical Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Yangtze River Pharmaceutical Product Portfolio
    • 6.5.5 Yangtze River Pharmaceutical Recent Developments/Updates
  • 6.6 Yabao Pharmaceutical Group Co., Ltd
    • 6.6.1 Yabao Pharmaceutical Group Co., Ltd Corporation Information
    • 6.6.2 Yabao Pharmaceutical Group Co., Ltd Description and Business Overview
    • 6.6.3 Yabao Pharmaceutical Group Co., Ltd Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Yabao Pharmaceutical Group Co., Ltd Product Portfolio
    • 6.6.5 Yabao Pharmaceutical Group Co., Ltd Recent Developments/Updates
  • 6.7 Yangzhou Pharmaceutical
    • 6.6.1 Yangzhou Pharmaceutical Corporation Information
    • 6.6.2 Yangzhou Pharmaceutical Description and Business Overview
    • 6.6.3 Yangzhou Pharmaceutical Mecobalamin Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Yangzhou Pharmaceutical Product Portfolio
    • 6.7.5 Yangzhou Pharmaceutical Recent Developments/Updates

7 Mecobalamin Injection Manufacturing Cost Analysis

  • 7.1 Mecobalamin Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Mecobalamin Injection
  • 7.4 Mecobalamin Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Mecobalamin Injection Distributors List
  • 8.3 Mecobalamin Injection Customers

9 Mecobalamin Injection Market Dynamics

  • 9.1 Mecobalamin Injection Industry Trends
  • 9.2 Mecobalamin Injection Growth Drivers
  • 9.3 Mecobalamin Injection Market Challenges
  • 9.4 Mecobalamin Injection Market Restraints

10 Global Market Forecast

  • 10.1 Mecobalamin Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Mecobalamin Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Mecobalamin Injection by Type (2022-2027)
  • 10.2 Mecobalamin Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Mecobalamin Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Mecobalamin Injection by Application (2022-2027)
  • 10.3 Mecobalamin Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Mecobalamin Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Mecobalamin Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Intramuscular Injection
    Intravenous Injection

    Segment by Application
    Hospital
    Drug Store
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Empower Pharmacy
    SGPharma
    Eisai China
    Harbin Medisan Pharmaceutical
    Yangtze River Pharmaceutical
    Yabao Pharmaceutical Group Co., Ltd
    Yangzhou Pharmaceutical

    Buy now